[1] KAYAWAKE H, OKUMURA N,YAMANASHI K, et al. Non-small cell lungcancer with pathological complete response:predictive factors and surgical outcomes[J].Gen Thorac Cardiovasc Surg,2019,67(9):773-781. [2] 林安琪, 陈雨晴, 张小利, 等. 非小细胞肺癌免疫治疗"超进展"[J]. 肿瘤, 2019, 39(8):680-690. [3] BESSE B,MAZIÈRES J,RIBASSIN-MAJED L, et al. Pazopanib or placebo in completely resected stage I NSCLC patients:results of the phase Ⅱ IFCT-0703 trial[J]. Ann Oncol,2017,28(5):1078-1083. [4] ANNE-MARIE B, DAVID E,MONIKA J,et al.When RON, MET, TAM in mesothelioma:all druggable for one, and one drug for all?[J]. J Thoracic Oncol,2017,12(1):S1356-S1357. [5] LI C, MORVARIDI S, LAM G, et al. MSP-RON signaling is activated in the transition from pancreatic intraepithelial neoplasia (PanIN) to pancreatic ductal adenocarcinoma (PDAC)[J]. Front Physiol,2019,10(4):147. [6] CHEN J F, YU B X, MA L, et al. RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells[J].Oncol Lett, 2018,15(5):6547-6554. [7] BAUMANN C,ULLRICH A,TORKA R. GAS6 expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance[J]. Mol Oncol, 2017,11(10):1430-1447. [8] O'DEA D,LYNG F M,NICHOLSON S,et al. Recent advances in the vibrational spectroscopic diagnosis of non-small cell lung cancer[J]. Vib Spectrosc,2019,10(4):104-107. [9] 杜卫东, 何超, 王达, 等. 巨噬细胞刺激蛋白受体过表达对癌细胞侵袭能力的初步研究[J]. 中华消化杂志, 2006, 26(5):304-307. [10] BABICKY M L, HARPER M M, CHAKEDT J, et al. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages[J]. Oncogene,2019,38(28):5599-5611. [11] CULLY M. Bone diseases:MST1R inhibitor prevents bone osteolysis[J]. Nat Rev Drug Discov,2017,16(3):164-165. [12] BENIGHT N M,WAGH P K,ZINSER G M,et al. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses[J]. Oncotarget,2015,6(19):17445-17461. [13] KOH X Y,KOH X H,HWANG L A,et al. Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase[J]. Oncogene,2019,38(48):7342-7356. [14] LIANG S Z,YU B,QIAN D M,et al. Human cytomegalovirus ie2 affects the migration of glioblastoma by mediating the different splicing patterns of RON through hnRNP A2B1[J]. Neuroreport, 2019,30(12):805-811. [15] 玄香兰, 安昌善. c-MET抑制剂联合EGFR-TKI对耐药肺癌细胞增殖、凋亡的影响及其机制[J]. 山东医药, 2017, 57(39):15-18. [16] 林珊,孟玲楠,珊丹,等.EGFR靶向抑制剂ZD1839联合放疗对非小细胞肺癌细胞凋亡的影响及其机制研究[J].解放军医药杂志,2019,31(3):34-38. [17] ZHOU Z W, LI X X, HE Z X, et al. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells[J]. Drug Des Devel Ther, 2015,9(1):1511-1554. [18] REN M,XU W J,XU T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway[J]. Artif Cells Nanomed Biotechnol,2019,47(1):1014-1021. [19] LIU L, BAI X Q, GAO Y, et al. PCSK9 promotes oxLDL-induced PC12 cell apoptosis through the bcl-2/bax-caspase 9/3 signaling pathway[J]. J Alzheimers Dis, 2017, 57(3):723-734. |